By Jessica Hagen
Augmedics, an augmented reality surgical-navigation platform, has scored $82.5 million in Series D financing led by CPMG.
Evidity Health Capital joins the round as a syndicate partner. Current investors Revival Healthcare Capital, H.I.G. Capital, Almeda Ventures and others participated in the round.
WHAT IT DOES
Augmedics xvision Spine System, which received FDA clearance in 2019, utilizes augmented reality to give surgeons a 3D image of a patient’s spinal anatomy directly in their line of sight during surgery, which allows surgeons to look at the patient instead of a remote screen.
The Illinois-based company will use the funds to support its growth in the U.S. and expand its platform capabilities to support mass adoption of its technology.
“To close an $82.5M round in the current fundraising environment is a testament to the dramatic impact Augmedics is making on the field of spine surgery. The accomplishment is underscored by the tremendous achievement of 4,000 patient lives impacted,” Kevin Hykes, Augmedics president and CEO, said in a statement.
“We are pleased to secure the resources to continue leading the market in the adoption of augmented reality spine surgery.”